Eureka Biotech Call 2026

6 May – 25 Sept 2026

Register
Register
Register

Project cooperationUpdated on 10 July 2026

sEV Platform from UC-MSCs: From Knee Application Toward New Areas

Business Development Manager at Cells for Cells S.A

Santiago, Chile

About

At MSC UC, we have reached first-in-human use of small extracellular vesicles (sEV) derived from umbilical cord mesenchymal stem cells (UC-MSCs), in a knee application. This milestone gave us real human safety data, representing significant de-risking for anyone interested in exploring this technology in other areas.

We now have this platform in hand and are looking to identify new application areas together with strategic partners, building on the safety groundwork already established. We also have access to sEV from different sourcing options, giving flexibility to adapt the platform to the needs of each collaboration.

What we bring: a characterized sEV platform derived from UC-MSCs, human safety data from a first-in-human knee application, and flexibility in sourcing.

What we are looking for: strategic partners interested in jointly exploring new applications for this platform, sharing know-how along the way.

Stage

  • Ideation - identifying the project idea

Topic

  • Next-generation therapeutics and modalities

Type

  • Project idea is seeking partners

Organisation

Cells for Cells S.A

Start-up

Santiago, Chile

Similar opportunities